4//SEC Filing
Papapetropoulos Spyridon 4
Accession 0001209191-21-020418
CIK 0001328143other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 3:24 PM ET
Size
5.1 KB
Accession
0001209191-21-020418
Insider Transaction Report
Form 4
Papapetropoulos Spyros
Director
Transactions
- Purchase
Common Stock
2021-03-11$5.06/sh+5,975$30,233→ 15,975 total
Footnotes (1)
- [F1]The shares were purchased at prices ranging from $4.85 to $5.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001832694
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 3:24 PM ET
- Size
- 5.1 KB